In the blockchain world, 1inch is one of the most extensively used networks. The 1inch first protocol is a decentralized exchange (DEX) that searches the blockchain for the best feasible paths to deliver the highest exchange rates and lucrative chances to its customers. 1inch employs a pathfinder algorithm that searches over 60 different locations across […]
What is 1inch Network (1inch) Read More »
Galera Therapeutics Inc. (GRTX) stock gained a further 7.92% in the after-hours on December 20. During the regular session, the stock saw a huge gain of $28.04% at its close of $3.79. GRTX continued going up in the after-hours, to reach $4.09 at 1.63 million shares. With no recent news, the stock seems to be
Galera Therapeutics Inc. (GRTX) stock Continues to Gain After Hours. Why? Read More »
Camber Energy, In. (CEI) stock went down by a further 6.93% in the after-hours following the announcement of a letter from the NYSE. It is the second time that the company had asked for a further extension from the NYSE for filing its Forms. In the regular session, the stock lost 3.81% at a volume
Camber Energy, In. (CEI) stock Plunges Further Deep After Hours. Reasons? Read More »
Following the news of full forgiveness of PPP loans, GEE Group Inc. (JOB) stock gained a huge 10.35% after hours. On December 20, the company announced full forgiveness of its $19.9 million PPP loans. During the regular session, JOB stock fluctuated between $0.45 and $0.47 at 1.57 million shares. The stock closed the session with
PPP Loans Full Forgiveness: GEE Group Inc. (JOB) Soars After Hours Read More »
Micron Technology, Inc. (MU) stock jumped up by 6.79% in the after-hours, following the announcement of Q1 earnings. The company declared its first-quarter fiscal 2022 earnings on Monday, December 20. During regular trading, the stock was in the red with a loss of 1.17% at its closing price of $82.03. Soon after the announcement, MU
Micron Technology, Inc. (MU) stock Rallies After Hours on Q1 FY2022 Earnings Read More »
Aldeyra Therapeutics Inc. (ALDX) stock fell by 36.33% in the after-hours following the announcement of results from its TRANQUILITY trial. On December 20, ALDX shared top-line results from its Phase 3 TRANQUILITY trial in dry eye disease. The company failed to meet the primary endpoint of the trial, hence causing the stock to plunge. During
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.